Literature DB >> 17922402

Cross-talk between CD31 and the signaling lymphocytic activation molecule-associated protein during interferon- gamma production against Mycobacterium tuberculosis.

Maria Florencia Quiroga1, Javier Oscar Jurado, Gustavo Javier Martínez, Virginia Pasquinelli, Rosa María Musella, Eduardo Abbate, Andrew C Issekutz, María Marta Bracco, Alejandro Malbran, Peter Allan Sieling, Eduardo Chuluyan, Verónica Edith García.   

Abstract

Effective host defense against tuberculosis requires Th1 cytokine responses. We studied the regulation of interferon (IFN)- gamma production during tuberculosis by investigating the role of CD31, a receptor that attenuates T cell receptor signals. After antigen stimulation, CD3(+)CD31(+) blood lymphocytes decreased in healthy donors and in tuberculosis patients with robust Th1 responses to Mycobacterium tuberculosis and IFN- gamma was secreted only by CD31(-) T cells. In contrast, in patients with weak Th1 cytokine responses to M. tuberculosis, the level of CD3(+)CD31(+) lymphocytes was increased and IFN- gamma production was low. Furthermore, the inverse relationship between CD31 expression and IFN- gamma production was in contrast to signaling lymphocytic activation molecule (SLAM) expression, an IFN- gamma inducer in tuberculosis. Interestingly, CD31 bound to SLAM-associated protein (SAP), an IFN- gamma inhibitor in tuberculosis, and when CD31 and SAP were coexpressed in lymphocytes, their association inhibited the IFN- gamma response to M. tuberculosis. Thus, CD31, when binding to SAP, interferes with Th1 responses, suggesting that CD31 has a key regulatory role in the signaling pathway(s) leading to the IFN- gamma response to M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922402     DOI: 10.1086/522522

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  4 in total

1.  CD137 differentially regulates innate and adaptive immunity against Mycobacterium tuberculosis.

Authors:  Darío A Fernández Do Porto; Javier O Jurado; Virginia Pasquinelli; Ivana B Alvarez; Romina H Aspera; Rosa M Musella; Verónica E García
Journal:  Immunol Cell Biol       Date:  2011-07-12       Impact factor: 5.126

2.  Bayesian approach to model CD137 signaling in human M. tuberculosis in vitro responses.

Authors:  Darío A Fernández Do Porto; Jerónimo Auzmendi; Delfina Peña; Verónica E García; Luciano Moffatt
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

3.  Restimulation-induced T-cell death through NTB-A/SAP signaling pathway is impaired in tuberculosis patients with depressed immune responses.

Authors:  Rodrigo E Hernández Del Pino; Joaquín M Pellegrini; Ana I Rovetta; Delfina Peña; Guadalupe I Álvarez; Agustín Rolandelli; Rosa M Musella; Domingo J Palmero; Alejandro Malbran; Virginia Pasquinelli; Verónica E García
Journal:  Immunol Cell Biol       Date:  2017-05-26       Impact factor: 5.126

4.  PGE2 displays immunosuppressive effects during human active tuberculosis.

Authors:  Joaquín Miguel Pellegrini; Candela Martin; María Paula Morelli; Julieta Aylen Schander; Nancy Liliana Tateosian; Nicolás Oscar Amiano; Agustín Rollandelli; Domingo Juan Palmero; Alberto Levi; Lorena Ciallella; María Isabel Colombo; Verónica Edith García
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.